AGTC develops genetic therapies to treat patients with rare, inherited conditions. Their most advanced therapy programs are designed to restore visual function and meet the needs of patients with rare, blinding conditions. As the anchor tenant at Foundation Park, AGTC worked directly with Concept Companies’ architect and developer to custom design a lab and office space to their specific type of work.  Phase 2 of AGTC is currently under construction, located in Building 2 of Foundation Park.